PMID- 31015797 OWN - NLM STAT- MEDLINE DCOM- 20190826 LR - 20220409 IS - 1466-1861 (Electronic) IS - 0962-9351 (Print) IS - 0962-9351 (Linking) VI - 2019 DP - 2019 TI - Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus. PG - 6737318 LID - 10.1155/2019/6737318 [doi] LID - 6737318 AB - Proinflammatory cytokines and the novel myokine irisin, a cleavage product of FNDC5, have been found to play a role in obesity and type 2 diabetes mellitus (T2DM). Irisin has been shown to increase browning of adipose tissue, thermogenesis, energy expenditure, and insulin sensitivity, yet its association with inflammatory markers is still limited. Circulating irisin has been found to be increased in obesity, while in adult subjects with T2DM decreased levels have been found. However, data establishing the association of circulating irisin in children and adolescents with T2DM has not been described in the literature. The objective of this study was to determine irisin plasma concentration and its association with metabolic and adiposity markers and with hs-CRP, a surrogate marker of inflammation used in clinical practice, in a pediatric population with T2DM. A cross-sample of 40 Mexican children and adolescents aged 7-17 were recruited, 20 diagnosed with T2DM and 20 healthy controls. Plasma irisin levels were found to be lower in the T2DM group compared with controls, which could be attributed to a reduced PGC-1alpha activity in muscle tissue with a consequent decrease in FNDC5 and irisin expression. Irisin concentration was found to be positively correlated with HDL-c, LDL-c, and total cholesterol, while negatively correlated with BMI, waist circumference, and triglycerides. However, after multiple regression analysis, only HDL-c correlation remained significant. hs-CRP was higher in the T2DM group and positively associated with adiposity markers, unfavorable lipid profile, insulin levels, and HOMA-IR, but no association with irisin was found. Given the favorable metabolic effects attributed to irisin, the low plasma levels found in children and adolescents with T2DM could exacerbate the inflammatory and metabolic imbalances and the intrinsic cardiovascular risk of this disease. We propose an "irisin-proinflammatory/anti-inflammatory axis" to explain the role of irisin as a metabolic regulator in obesity and T2DM. FAU - Elizondo-Montemayor, Leticia AU - Elizondo-Montemayor L AUID- ORCID: 0000-0002-2076-1769 AD - Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Ave. Morones Prieto 3000, Monterrey, N.L. 64710, Mexico. AD - Tecnologico de Monterrey, Center for Research in Clinical Nutrition and Obesity, Ave. Morones Prieto 300, Monterrey, N.L. 64710, Mexico. AD - Tecnologico de Monterrey, Cardiovascular and Metabolomics Research Group, Hospital Zambrano Hellion, San Pedro Garza Garcia, P.C. 66278, Mexico. FAU - Gonzalez-Gil, Adrian M AU - Gonzalez-Gil AM AUID- ORCID: 0000-0002-3379-1916 AD - Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Ave. Morones Prieto 3000, Monterrey, N.L. 64710, Mexico. AD - Tecnologico de Monterrey, Center for Research in Clinical Nutrition and Obesity, Ave. Morones Prieto 300, Monterrey, N.L. 64710, Mexico. FAU - Tamez-Rivera, Oscar AU - Tamez-Rivera O AUID- ORCID: 0000-0002-1199-7884 AD - Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Ave. Morones Prieto 3000, Monterrey, N.L. 64710, Mexico. AD - Tecnologico de Monterrey, Center for Research in Clinical Nutrition and Obesity, Ave. Morones Prieto 300, Monterrey, N.L. 64710, Mexico. FAU - Toledo-Salinas, Carla AU - Toledo-Salinas C AUID- ORCID: 0000-0002-9354-2479 AD - Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Ave. Morones Prieto 3000, Monterrey, N.L. 64710, Mexico. AD - Tecnologico de Monterrey, Center for Research in Clinical Nutrition and Obesity, Ave. Morones Prieto 300, Monterrey, N.L. 64710, Mexico. FAU - Peschard-Franco, Mariana AU - Peschard-Franco M AUID- ORCID: 0000-0003-1133-4877 AD - Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Ave. Morones Prieto 3000, Monterrey, N.L. 64710, Mexico. AD - Tecnologico de Monterrey, Center for Research in Clinical Nutrition and Obesity, Ave. Morones Prieto 300, Monterrey, N.L. 64710, Mexico. FAU - Rodriguez-Gutierrez, Nora A AU - Rodriguez-Gutierrez NA AUID- ORCID: 0000-0003-1972-0625 AD - Hospital Regional de Alta Especialidad Materno Infantil, Ave. San Rafael 450, Guadalupe, P.C. 67140, Mexico. FAU - Silva-Platas, Christian AU - Silva-Platas C AUID- ORCID: 0000-0003-3760-8733 AD - Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Ave. Morones Prieto 3000, Monterrey, N.L. 64710, Mexico. AD - Tecnologico de Monterrey, Cardiovascular and Metabolomics Research Group, Hospital Zambrano Hellion, San Pedro Garza Garcia, P.C. 66278, Mexico. FAU - Garcia-Rivas, Gerardo AU - Garcia-Rivas G AUID- ORCID: 0000-0003-4731-3293 AD - Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Ave. Morones Prieto 3000, Monterrey, N.L. 64710, Mexico. AD - Tecnologico de Monterrey, Cardiovascular and Metabolomics Research Group, Hospital Zambrano Hellion, San Pedro Garza Garcia, P.C. 66278, Mexico. LA - eng PT - Journal Article DEP - 20190320 PL - United States TA - Mediators Inflamm JT - Mediators of inflammation JID - 9209001 RN - 0 (FNDC5 protein, human) RN - 0 (Fibronectins) RN - 0 (PPARGC1A protein, human) RN - 0 (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha) RN - 0 (Triglycerides) RN - 9007-41-4 (C-Reactive Protein) MH - Adolescent MH - Anthropometry MH - Body Mass Index MH - C-Reactive Protein/*metabolism MH - Child MH - Diabetes Mellitus, Type 2/*blood/*metabolism MH - Female MH - Fibronectins/*blood MH - Humans MH - Male MH - Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/blood MH - Triglycerides/blood MH - Waist Circumference PMC - PMC6446111 EDAT- 2019/04/25 06:00 MHDA- 2019/08/27 06:00 PMCR- 2019/03/20 CRDT- 2019/04/25 06:00 PHST- 2018/12/07 00:00 [received] PHST- 2019/01/28 00:00 [revised] PHST- 2019/02/07 00:00 [accepted] PHST- 2019/04/25 06:00 [entrez] PHST- 2019/04/25 06:00 [pubmed] PHST- 2019/08/27 06:00 [medline] PHST- 2019/03/20 00:00 [pmc-release] AID - 10.1155/2019/6737318 [doi] PST - epublish SO - Mediators Inflamm. 2019 Mar 20;2019:6737318. doi: 10.1155/2019/6737318. eCollection 2019.